Truist Securities Adjusts Price Target on Boston Scientific to $110 From $100, Keeps Buy Rating

USA
EnglishUK
EnglishIndia
EnglishAustralia
EnglishCanada
EnglishFrance
FrançaisSuisse
FrançaisEspaña
EspañolDeutschland
DeutschÖsterreich
DeutschSchweiz
DeutschBelgië
NederlandsNederland
NederlandsItalia
ItalianoSverige
Svenska
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
106.06 USD | -0.08% |
|
+1.07% | +18.83% |
02-13 | Boston Scientific Insider Sold Shares Worth $1,368,073, According to a Recent SEC Filing | MT |
02-13 | Boston Scientific Insider Sold Shares Worth $671,249, According to a Recent SEC Filing | MT |